Bruker (BRKR) Non Operating Investment Income (2026)
Bruker's (BRKR) quarterly Non Operating Investment Income came in at $12.2 million in Q1 2026.
Bruker (BRKR) Non Operating Investment Income (2026) Analysis & Trends
Bruker (BRKR) has 1 years of Non Operating Investment Income data on file, last reported at $12.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | - |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | - |
| 10 | Bruker | 9.21 Bn | 9.21 Bn | 416.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.20 Mn |
| Mar 31, 2026 | 12.20 Mn |